In 2014, the National Institutes of Health established guidelines
for preclinical experimental design. These guidelines were designed to
encourage researchers to adopt best practices, such as randomization and the
inclusion of both male and female lab animals. Many thought this might result
in a more radical change in favor of equal research on males and females. A report
in May of 2017 showed that the best-practice guidelines were not widely being
adhered to. Researchers
reviewed 4,000 papers published from 2006 to 2016 in five journals
under the umbrella of the American Heart Association: Circulation, Circulation
Research, Hypertension, Stroke, and Arteriosclerosis, Thrombosis, and Vascular
Biology. They were comparing the preclinical design against four criteria
related to the MIH guidelines of 2014. The analysis showed that male animals were
still being used about the same in pre-clinical trials or were increasing. Of
the five journals reviewed, Stroke provided the best record of compliance. I am
hopeful that is a start.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment